11. P574: CPX-351 COMBINED WITH HEMATOPOIETIC CELL TRANSPLANTATION WITH REGULATORY AND CONVENTIONAL T CELL IMMUNOTHERAPY FOR HIGH-RISK ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Sciabolacci, S.; Ruggeri, L.; Cardinali, V.; Brunetti, L.; Tricarico, S.; Saldi, S.; Marzuttini, F.; Griselli, M.; Perta, G.; Viglione, V.; Cimino, G.; Osmani, A.; Caridi, M.; Sembenico, R.; Terenzi, A.; Zei, T.; Iacucci Ostini, R.; Martelli, M. F.; Falini, B.; Velardi, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. PO-0676: Dosimetric predictive factors for radiation pneumonitis in sterotactic body radiotherapy. (April 2015) Authors: Arcidiacono, F.; Bellavita, R.; Falcinelli, L.; Saldi, S.; Matrone, F.; Mendichi, M.; Salari, B.; Bini, V.; Aristei, C. Journal: Radiotherapy and oncology Issue: Volume 115(2015)Supplement 1 Page Start: S330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. PO-0921: Total Body Irradiation and adoptive immunotherapy in pediatric HLA-haploidentical transplantation. (November 2020) Authors: Saldi, S.; Panizza, B.M.; Massei, M.S.; Capolsini, I.; Fulcheri, C.; Ingrosso, G.; Chierchini, S.; Mariucci, C.; Perrucci, E.; Caniglia, M.; Aristei, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. PO-1174 Radiation therapy as bridging strategy before infusion of CAR T in non hodgkin lymphoma patients. (May 2022) Authors: Saldi, S.; Perriello, V.; Falini, L.; Ingrosso, G.; Zucchetti, C.; Fulcheri, C.P.L.; Di Pilato, A.C.; Camilli, F.; Falini, B.; Aristei, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S995 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. PV-0367 TMLI-based low-toxic myeloablative conditioning regimen in haploidentical HSCT for AML. (April 2019) Authors: Aristei, C.; Lancellotta, V.; Carotti, A.; Zucchetti, C.; Saldi, S.; Pierini, A.; Ruggeri, L.; Piccinini, S.; Amico, L.; Iacco, M.; Velardi, A.; Martelli, M.F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗